Red flag: Avoid any provider who claims there are "zero risks." All medical interventions carry some level of risk
Hence, this study posits that IGF-1 analogs may have a positive potential within the context of growth hormone deficiency research
Nevertheless, unimolecular GIPGLP-1 co-agonism is an effective therapy for type 2 diabetes, associated with weight loss and reduction of fat mass, in rats, mice, monkeys and humans [66]
doi:10.1186/s12916-022-02477-z
Many patients report clearer thinking, better skin, and a noticeable drop in fatigue after just a few treatments
Microdosing is still a prescription GLP-1, but at a small dose